Evexia Lifecare share price
BSE: 524444Chemicals & PetrochemicalsSmall Cap
Last close ₹1.82down ₹0.09 (4.71%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹1.91.
52-week range of traded prices to 23 Oct 2026
₹0.47Low, 6 Apr 2026₹2.28High, 14 Oct 2026
- Under BSE's long-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 24 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹404 Cr2,235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 May 2026
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 19,82,479
Results
Standalone, as consolidated accounts are on record for only 9 of the last ten years; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 7 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹30 Crdown 15.69%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.41 Crdown 11.65%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 1.4%
Revenue by year
Net profit by year, a loss in red
The years either side of a change of basis do not compare. From the year to Mar 2019, the company's revenue for that year, ₹58 Cr, differs from its quarters added, ₹92 Cr.
| ₹ crore | Sep 2024Filed 15 Nov | Dec 2024Filed 14 Feb | Mar 2025Filed 16 Jun | Jun 2025Filed 14 Aug | Sep 2025Filed 15 Nov | Dec 2025Filed 18 Feb | Mar 2026Filed 9 May | Jun 2026Filed 7 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.7 | 21.6 | 15.2 | 20.7 | 25.0 | 24.6 | 35.2 | 29.7 |
| Net profit | 0.7 | 0.3 | −0.5 | 0.6 | 0.3 | 0.4 | 0.5 | 0.4 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.6% | 1.2% | −3.2% | 2.8% | 1.3% | 1.7% | 1.3% | 1.4% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Single segment, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −79.7% | +109.0% | −90.3% | 0.0% |
| 3 years | −31.2% | – | – | 0.0% |
| 5 years | −48.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Trading - Chemicals, 17 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Evexia Lifecare in market cap.
Evexia Lifecare is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Uniphos EnterprisesUNIENTER | 567 | 28.0 | 0.2 | – | −77.1% | – | 0.8% | −0.2% | 4.29% |
 Veritas (India)VERITAS | 396 | – | 0.1 | 11.5 | −12.9% | −100.9% | 0.0% | 0.8% | 0.03% |
 Vinyl Chemicals (India)VINYLINDIA | 367 | 19.7 | 2.8 | 30.0 | −3.2% | −14.6% | 14.5% | 9.0% | 3.50% |
 Bhavik EnterprisesBHAVIK | 292 | 21.5 | 1.8 | – | – | – | 8.2% | – | 0.00% |
 Shankar Lal Rampal Dye-ChemSRD | 246 | 13.4 | 2.0 | 10.5 | +12.4% | +51.8% | 15.9% | 17.4% | 0.13% |
| Shiv TexchemSHIVTEXCHEM | 231 | 3.0 | 0.6 | – | +26.1% | +61.7% | 20.9% | – | 0.00% |
 A-1A1L | 226 | 26.4 | 4.2 | 16.6 | +38.7% | +151.0% | 16.5% | 13.7% | 1.02% |
 DhariwalcorpDHARIWAL | 204 | 23.8 | 3.3 | – | +1.2% | +141.5% | 17.9% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
19 Oct · Board meeting
Meeting on 24 Oct 2026: quarterly results13 Oct · Management
13 Oct · Board meeting
5 Oct · Meeting
Evexia Lifecare share price by year
Each calendar year to 2025.Evexia Lifecare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1.64 | −52.5% | 3.54 | 1.64 |
| 2024 | 3.45 | +83.5% | 4.26 | 1.90 |
| 2023 | 1.88 | +19.7% | 3.10 | 1.31 |
| 2022 | 1.57 | −69.0% | 5.48 | 1.45 |
| 2021 | 5.07 | −66.6% | 16.50 | 4.86 |
| 2020 | 15.15 | +68.2% | 16.00 | 7.42 |
| 2019 | 9.01 | +247.0% | 9.58 | 2.45 |
| 2018 | 2.60 | +33.1% | 3.77 | 1.48 |
| 2017 | 1.95 | −29.5% | 4.12 | 1.37 |
| 2016 | 2.77 | +279.8% | 2.84 | 0.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 19,82,479 |
| 22 Oct 2026 | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 | 2,85,599 |
| 21 Oct 2026 | 2.15 | 2.16 | 2.01 | 2.01 | 2.04 | 61,30,206 |
| 19 Oct 2026 | 2.20 | 2.22 | 2.10 | 2.11 | 2.14 | 69,59,048 |
| 16 Oct 2026 | 2.27 | 2.27 | 2.21 | 2.21 | 2.23 | 36,18,029 |
| 15 Oct 2026 | 2.22 | 2.27 | 2.22 | 2.24 | 2.25 | 39,76,134 |
| 14 Oct 2026 | 2.26 | 2.28 | 2.21 | 2.24 | 2.25 | 1,08,21,610 |
| 13 Oct 2026 | 2.20 | 2.23 | 2.17 | 2.22 | 2.20 | 41,96,043 |
| 12 Oct 2026 | 2.10 | 2.17 | 2.10 | 2.16 | 2.15 | 64,83,366 |
| 9 Oct 2026 | 2.00 | 2.11 | 2.00 | 2.11 | 2.07 | 95,03,878 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 24 May 2022 | Split | 0.5000 | Each share became 2. |
| 26 Jul 2021 | Split | 0.2000 | Each share became 5. |
| 23 Oct 2015 | Bonus | 0.7500 | Holders received 1 bonus share for every 3 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- Legal name
- EVEXIA LIFECARE LIMITED
- BSE code
- 524444
- ISIN
- INE313M01030
- Industry
- Chemicals & Petrochemicals
- Listed
- Mar 1994
- Face value
- ₹1
- CIN
- L23100GJ1990PLC014692
- Corporate identity number, the registrar of companies' code for it